Ciftci Orcun, Yilmaz Kerem Can, Karacaglar Emir, Yilmaz Mustafa, Ozin Bulent, Muderrisoglu Ibrahim Haldun
Department of Cardiology, Başkent University School of Medicine, Ankara Hospital, Ankara, Turkey.
Department of Cardiology, Başkent University School of Medicine, Adana Hospital, Adana, Turkey.
Eurasian J Med. 2019 Jun;51(2):165-171. doi: 10.5152/eurasianjmed.2019.18342.
AF may create confusion about the presence of severe or unstable coronary artery disease in cases with unstable symptoms. Novel scores and markers are needed to determine severe coronary artery disease in such patients. We aimed to test the newly developed CHADS-VASc-FSH score, developed by adding family history for coronary artery disease, hyperlipidemia, and smoking to the original CHADS-VASc score, in the prediction of severe CAD in patients with AF and unstable symptoms.
We retrospectively analyzed 72 patients presenting to Başkent Universtiy School of Medicine Hospital between April 2011 and January 2016. The CHADSVASc-FSH score was assessed for the prediction of severe CAD.
Seventy-two patients aged 65.7±11.2 years were enrolled. Thirty-five (48.6%) patients had severe CAD and 11 (15.3%) had unstable CAD. patients with severe coronary artery disease had a significantly greater CHADSVASC-FSH score (5 (1-8) vs 3(0-7); p<0.05). The CHADSVASC-FSH score independently predicted severe CAD, with a CHADSVASc-FSH score of 3 or greater having a sensitivity of 77.1% and a specificity of 56.8% for severe CAD.
Among patients with AF and unstable symptoms, the CHADSVASc-FSH score independently predicts severe CAD.
房颤可能会使症状不稳定的患者中严重或不稳定冠状动脉疾病的存在情况变得模糊不清。需要新的评分和标志物来确定此类患者的严重冠状动脉疾病。我们旨在测试新开发的CHADS-VASc-FSH评分,该评分是在原始CHADS-VASc评分基础上增加了冠状动脉疾病、高脂血症和吸烟的家族史,用于预测房颤和症状不稳定患者的严重冠状动脉疾病。
我们回顾性分析了2011年4月至2016年1月在巴斯肯特大学医学院医院就诊的72例患者。评估CHADSVASc-FSH评分对严重冠状动脉疾病的预测能力。
纳入72例年龄为65.7±11.2岁的患者。35例(48.6%)患者患有严重冠状动脉疾病,11例(15.3%)患有不稳定冠状动脉疾病。严重冠状动脉疾病患者的CHADSVASC-FSH评分显著更高(5(1-8)对3(0-7);p<0.05)。CHADSVASC-FSH评分独立预测严重冠状动脉疾病,CHADSVASc-FSH评分为3或更高时,对严重冠状动脉疾病的敏感性为77.1%,特异性为56.8%。
在房颤和症状不稳定的患者中,CHADSVASc-FSH评分独立预测严重冠状动脉疾病。